142 related articles for article (PubMed ID: 37854918)
1. Pathogenetic model of survivin-dependent molecular signalling pathways in tumorigenesis of oral cancer and precursor lesions.
Aggarwal D; Shetty DC; Jain A; Gulati N; Juneja S
J Oral Maxillofac Pathol; 2023; 27(2):287-294. PubMed ID: 37854918
[TBL] [Abstract][Full Text] [Related]
2. Expression of inhibitor of apoptosis family proteins in human oral squamous cell carcinogenesis.
Chen YK; Huse SS; Lin LM
Head Neck; 2011 Jul; 33(7):985-98. PubMed ID: 20967871
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of tissue p53 protein expression and serum p53 antibodies in oral potentially malignant disorders: Relative to oral squamous cell carcinoma.
Khan AS; Ahmad S; Ullah Z; Sadiq N; Haq M; Sheikh AK
J Taibah Univ Med Sci; 2022 Jun; 17(3):415-423. PubMed ID: 35722241
[TBL] [Abstract][Full Text] [Related]
4. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
[TBL] [Abstract][Full Text] [Related]
5. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
[TBL] [Abstract][Full Text] [Related]
6. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
7. Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study.
Rajanna VR; Raveendranath MC; Kathiresan S; Srinivasan S; Ilango J
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S382-S388. PubMed ID: 33149491
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and Expression of Survivin in Potentially Malignant Lesions and Squamous Cell Carcinoma: A Comparative Study.
Sakthivel R; Ramamoorthy A; Jeddy N; Singaram M
Cureus; 2020 Apr; 12(4):e7551. PubMed ID: 32382455
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Srinivasan V; Shyam N; Kumar GK; Narayen V; Konda P; Swetha Rani K
Cureus; 2023 May; 15(5):e38467. PubMed ID: 37273383
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Embryonic Cancer Stem Cells' Biomarkers SOX2 and OCT3/4 in Oral Leukoplakias and Squamous Cell Carcinomas: A Preliminary Study.
Zisis V; Andreadis D; Anastasiadou PA; Akrivou M; Vizirianakis IS; Anagnostou L; Malamos D; Paraskevopoulos K; Poulopoulos A
Cureus; 2023 Sep; 15(9):e45482. PubMed ID: 37859926
[TBL] [Abstract][Full Text] [Related]
11. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
13. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
16. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
Jinfeng M; Kimura W; Sakurai F; Moriya T; Takeshita A; Hirai I
Int J Gastrointest Cancer; 2002; 32(2-3):73-81. PubMed ID: 12794243
[TBL] [Abstract][Full Text] [Related]
17. TNFα Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model.
Chadwick JW; Macdonald R; Ali AA; Glogauer M; Magalhaes MA
Front Oncol; 2021; 11():741013. PubMed ID: 34650923
[TBL] [Abstract][Full Text] [Related]
18. KAI-1 and p53 expression in oral squamous cell carcinomas: Markers of significance in future diagnostics and possibly therapeutics.
Patil NN; Wadhwan V; Chaudhary M; Nayyar AS
J Oral Maxillofac Pathol; 2016; 20(3):384-389. PubMed ID: 27721601
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of survivin expression in leukoplakia, lichen planus, and oral squamous cell carcinoma: An immunohistochemical study.
Angelin D; Nair BJ
J Cancer Res Ther; 2020; 16(3):569-574. PubMed ID: 32719269
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of sprouty 1 protein in human oral squamous cell carcinogenesis.
Wang YY; Wang WC; Su CW; Hsu CW; Yuan SS; Chen YK
J Dent Sci; 2021 Jan; 16(1):21-28. PubMed ID: 33384774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]